---
title: "Legend Biotech (LEGN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LEGN.US/norm.md"
symbol: "LEGN.US"
name: "Legend Biotech"
parent: "https://longbridge.com/en/quote/LEGN.US.md"
datetime: "2026-05-19T19:18:44.959Z"
locales:
  - [en](https://longbridge.com/en/quote/LEGN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LEGN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LEGN.US/norm.md)
---

# Legend Biotech (LEGN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3000 | -0.1807 | -0.2200 | -0.6809 | -0.5497 |
| ROE | -22.05% | -12.24% | -15.51% | -48.85% | -39.25% |
| Revenue | 305.10M | 306.38M | 272.33M | 255.06M | 195.00M |
| Net income | -54.30M | -30.82M | -39.69M | -125.38M | -101.00M |
| Operating income | -49.80M | -20.60M | -43.45M | -21.88M | -51.70M |
| Gross margin | 14.26% | 26.63% | 16.11% | 23.04% | 11.18% |
| Net margin | -17.80% | -10.06% | -14.57% | -49.16% | -51.79% |
| Profit quality | - | - | -150.87% | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.60B | 1.73B | 1.71B | 1.69B | 1.62B |
| Leverage | 1.65 | 1.73 | 1.69 | 1.63 | 1.59 |
| BVPS | 5.21 | 5.42 | 5.48 | 5.61 | 5.53 |
| Turnover | 0.7091 | 0.6045 | 0.5271 | 0.4569 | 0.4296 |
| Cash & STI | 834.60M | 948.60M | 992.59M | 967.55M | 1.01B |
| Inv & Rec | 37.10M | 32.00M | 29.18M | 35.59M | 30.93M |
| LT assets | 452.50M | 401.50M | 253.74M | 233.60M | 206.03M |
| Net debt | -445.30M | -534.90M | -582.35M | -579.64M | -642.57M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -85.10M | -12.21M | 28.80M | -13.04M | -103.60M |
| Investing CF | -168.00M | 638.49M | -20.00M | -165.53M | 256.60M |
| Financing CF | -1.20M | -647000.00 | 670000.00 | -990000.00 | 600000.00 |
| Free CF | -31.32M | -20.85M | 30.37M | -55.41M | -109.29M |
| OCF coverage | -967.05% | -91.58% | 513.66% | -124.36% | -3700.00% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -7.50M | -12.37M | -5.00M | -9.22M | -2.00M |